Leading Big Data company developing platform with clinical and genomic data from 5 million subjects, to transform drug development and bring clinical benefits to patients. BC Platforms, a world leader in genomic data management solutions, today announces that it has closed a $USD 10 million financing round. The round was led by Debiopharm Innovation Fund in conjunction […]
Licensing agreement will support Oxford Genetics growing bio-therapeutic discovery, development and manufacturing service business. Oxford – Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery and development, today announces it has signed a non-exclusive licensing agreement with ERS Genomics to access its foundational intellectual property related to CRISPR/Cas9 gene editing technology. […]
Boulder, CO – Muse bio, a privately-held company leading the development of next-generation genome engineering capabilities, today announced Dr. John Stuelpnagel, co-founder, first CEO and former COO of Illumina and a well-known genomics industry entrepreneur, will become Chairman of Muse bio’s Board of Directors. In addition to Illumina, Dr. Stuelpnagel has co-founded and held senior […]
Quantitative, label-free characterization system covered by patent enables sensitive kinetic binding and affinity data for life science research. San Diego, CA The United States Patent and Trademark Office has issued U.S. Patent No. 9,618,476 to Nanomedical Diagnostics, a biotech company pioneering label-free graphene biosensors for use in drug discovery. The patent covers any holistic graphene […]
LAMPIRE Biological Laboratories, Inc., announced it has completed the acquisition of H. B. Custom Media, based out of the Ben Franklin Tech Ventures Business Center, in Bethlehem, PA. The acquisition includes all equipment, materials and personnel. LAMPIRE Biological Laboratories, Inc., is a provider of human and animal blood and blood products, OMNI C3 cell culture […]
Kit enables flexibility in development and optimization of ELISA assays Cambridge, UK: Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, today announced it has introduced the FlexLISA® kit, providing a flexible tool for development and optimization of sandwich ELISA assays. The FlexLISA kit allows researchers to covalently conjugate up to 3 capture and […]
Acquisition strengthens portfolio with best-selling labelling technology Lightning Link® Combined 2017 pro-forma revenues expected to exceed EUR 10 million Acquisition to be financed by way of a rights issue and a private placement excluding pre-emptive rights with total proceeds of up to EUR 10 mio Two million shares to be offered to Innova shareholders as […]
We’re thrilled on announce that we’ll be unveiling the newest addition to our bioinformatics portfolio – CLC Genomics Cloud Engine – at this year’s Bio IT World Conference & Expo! Join us in Boston, May 23-25, and register for early access for our new enterprise-wide solution which allows you to analyse NGS data where they […]
Perten and Bioo Scientific are both part of PerkinElmer’s Food business unit. Bioo Scientific offers food safety test kits which complement Perten’s range of grain, feed, and food analysis instruments. Based in Austin, Texas, USA, Bioo Scientific has developed and supplied food and feed safety test kits since 2003. Bioo Scientific offers a wide range […]
Joint study will accelerate development of physiologically relevant 3D models for anti-cancer drug screening. Schlieren, Switzerland – InSphero AG today announced a collaboration with the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health, to identify anti-cancer agents with cytotoxic activity in 3D tumor models. In this joint project, NCATS will […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
